Ursofalk pills 500mg №50

Composition:

1 pill contains ursodeoxycholic acid 500 mg

Release form:

Tablets for ingestion of 50 pieces per pack

Pharmachologic effect:

Hepatoprotector. It has a choleretic effect. Reduces the synthesis of cholesterol in the liver, its absorption in the intestines and concentration in bile, increases the solubility of cholesterol in the biliary system, stimulates the formation and excretion of bile. Reduces the lithogenicity of bile, increases the content of bile acids. It causes increased gastric and pancreatic secretion, enhances the activity of lipase.

It has a hypoglycemic effect.

It causes partial or complete dissolution of cholesterol stones when ingested, reduces the saturation of bile with cholesterol, which helps mobilize cholesterol from gallstones.

It has an immunomodulatory effect, affects immunological reactions in the liver: reduces the expression of certain antigens on the hepatocyte membrane, affects the number of T-lymphocytes, the formation of interleukin-2, reduces the number of eosinophils.

Indications for use:

• dissolving cholesterol gallstones;
• biliary reflux gastritis;
• primary biliary cirrhosis in the absence of signs of decompensation (symptomatic treatment);
• chronic hepatitis of various genesis;
• primary sclerosing cholangitis, cystic fibrosis (cystic fibrosis);
• non-alcoholic steatohepatitis;
• alcoholic liver disease;
• biliary dyskinesia.

Dosage and administration:

Taken inside.

The multiplicity and dosage of the intake depends on the disease and the general condition and is chosen by the doctor individually.

Children under the age of 3 years, as well as patients with difficulty in swallowing tablets, are advised to use the drug Ursofalk in the form of a suspension.

Contraindications:

• X-ray positive (high calcium) gallstones;
• nonfunctioning gallbladder;
• acute inflammatory diseases of the gallbladder, bile ducts and intestines;
• cirrhosis of the liver in the stage of decompensation;
• severe renal impairment;
• severe liver dysfunction;
• pronounced dysfunction of the pancreas;
• violation of the contractility of the gallbladder;
• obstruction of the biliary tract (blockage of the common bile duct or cystic duct);
• frequent episodes of biliary colic;
• unsuccessfully performed portoenterostomy or cases of the lack of recovery of normal bile flow in children with biliary atresia.
• children's age up to 3 years.
• pregnancy;
• lactation period (breastfeeding);
• hypersensitivity to the drug.

Special instructions:

Ursofalk is administered under the supervision of a physician.

Effects on the ability to drive vehicles and moving mechanisms have been identified.

Storage conditions:

The drug should be stored out of the reach of children at a temperature up to 25 ° C.